Sigyn Therapeutics (SIGY) Intangibles (2016 - 2023)
Sigyn Therapeutics (SIGY) posted Intangibles of $10799.0 for Q4 2023, little changed sequentially from $10799.0 in Q3 2023, and little changed YoY from $10799.0 in Q4 2022.
Sigyn Therapeutics (SIGY) Intangibles (2016 - 2023) Analysis & Trends
Sigyn Therapeutics has reported Intangibles for 8 years, with the latest figure at $10799.0 in Q4 2023.
- Quarterly Intangibles changed 0.0% year-over-year to $10799.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $10799.0 (changed 0.0% YoY) and the FY2023 annual result came in at $10799.0, changed 0.0% from the prior year.
- Intangibles held at $10799.0 in Q4 2023 per SIGY's latest filing, from $10799.0 in the prior quarter.
- Over five years, Intangibles peaked at $97034.0 in Q1 2019 and troughed at $300.0 in Q2 2023.
- A 5-year average of $24991.8 and a median of $10799.0 in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2022 and 2023: Intangibles jumped 89.46% in 2022, then slumped 92.31% in 2023.
- Over 5 years, Intangibles stood at $50425.0 in 2019, then tumbled by 56.56% to $21905.0 in 2020, then tumbled by 73.98% to $5700.0 in 2021, then surged by 89.46% to $10799.0 in 2022, then changed by 0.0% to $10799.0 in 2023.
- According to Business Quant data, Intangibles over the past three periods registered $10799.0, $10799.0, and $300.0 for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 266.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 60.96 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 93.49 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Sigyn Therapeutics | 48,161.31 | -37,409.69 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 10,799.00 |
| Sep 30, 2023 | 10,799.00 |
| Jun 30, 2023 | 300.00 |
| Mar 31, 2023 | 1,200.00 |
| Dec 31, 2022 | 10,799.00 |
| Sep 30, 2022 | 10,799.00 |
| Jun 30, 2022 | 3,900.00 |
| Mar 31, 2022 | 10,799.00 |
| Dec 31, 2021 | 5,700.00 |
| Sep 30, 2021 | 6,600.00 |
| Jun 30, 2021 | 7,499.00 |
| Mar 31, 2021 | 11,551.00 |
| Dec 31, 2020 | 21,905.00 |
| Sep 30, 2020 | 22,061.00 |
| Jun 30, 2020 | 31,516.00 |
| Mar 31, 2020 | 40,970.00 |
| Dec 31, 2019 | 50,425.00 |
| Sep 30, 2019 | 64,441.00 |
| Jun 30, 2019 | 80,738.00 |
| Mar 31, 2019 | 97,034.00 |